NO20071232L - Indolylmaleimide derivatives as protein kinase C inhibitors - Google Patents

Indolylmaleimide derivatives as protein kinase C inhibitors

Info

Publication number
NO20071232L
NO20071232L NO20071232A NO20071232A NO20071232L NO 20071232 L NO20071232 L NO 20071232L NO 20071232 A NO20071232 A NO 20071232A NO 20071232 A NO20071232 A NO 20071232A NO 20071232 L NO20071232 L NO 20071232L
Authority
NO
Norway
Prior art keywords
inhibitors
protein kinase
indolylmaleimide derivatives
indolylmaleimide
derivatives
Prior art date
Application number
NO20071232A
Other languages
Norwegian (no)
Inventor
Rainer Albert
Richard Sedrani
Nigel Graham Cooke
Claus Ehrhardt
Jean-Pierre Evenou
Peter Von Matt
Juergen Wagner
Gerhard Zenke
Sylvain Cottens
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2001/012785 external-priority patent/WO2002038561A1/en
Publication of NO20071232L publication Critical patent/NO20071232L/en
Application filed by Novartis Ag filed Critical Novartis Ag

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Indolylmaleimidderivater irmbefattende enten en substituert fenyl-, naffyl-, tetrahydronaftyl-, kinazolinyl-, kinolyl-, isokinolyl- eller pyrimidinylrest som har interessante farmasøytiske egenskaper, for eksempel i behandling og/eller forebyggelse av T-celleformidlede, akutte eller kroniske, inflammatoriske sykdommer eller forstyrrelser, autoimmunsykdommer, transplantatrejeksjon eller kreft.Indolylmaleimide derivatives comprising either a substituted phenyl, naffyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue having interesting pharmaceutical properties, for example in the treatment and / or prevention of T-cell mediated, acute or chronic, inflammatory or chronic disorders, autoimmune diseases, graft rejection or cancer.

NO20071232A 2000-11-07 2007-03-06 Indolylmaleimide derivatives as protein kinase C inhibitors NO20071232L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24640000P 2000-11-07 2000-11-07
PCT/EP2001/012785 WO2002038561A1 (en) 2000-11-07 2001-11-05 Indolylmaleimide derivatives as protein kinase c inhibitors

Publications (1)

Publication Number Publication Date
NO20071232L true NO20071232L (en) 2003-07-04

Family

ID=33449385

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071232A NO20071232L (en) 2000-11-07 2007-03-06 Indolylmaleimide derivatives as protein kinase C inhibitors

Country Status (3)

Country Link
EC (1) ECSP034578A (en)
NO (1) NO20071232L (en)
ZA (1) ZA200303426B (en)

Also Published As

Publication number Publication date
ZA200303426B (en) 2004-04-22
ECSP034578A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
WO2002038561A8 (en) Indolylmaleimide derivatives as protein kinase c inhibitors
WO2002085857A3 (en) Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
CY1118516T1 (en) Quinazolinones as Inhibitors of Human 3-Kinase Delta Phosphatidylinositol
BRPI0418112A (en) heterocyclic bicyclic p-38 kinase inhibitors
ATE466580T1 (en) AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITORS
ATE468336T1 (en) AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITORS
ATE365733T1 (en) COMPOSITIONS USEFUL AS PROTEIN KINASE INHIBITORS
NO20014303D0 (en) JAK-3 inhibitors for the treatment of allergic disorders
NO20053470L (en) Triazolopyridazines as protein kinase inhibitors
TR199900049T2 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors.
NO20070453L (en) Condensed heterocyclic kinase inhibitors
EP1140840A4 (en) -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
DK1202736T3 (en) Nicotine in therapeutic angiogenesis and vasculogenesis
ATE305932T1 (en) RAPANYCIN29-ENOLE
WO2002096361A3 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
ATE384724T1 (en) CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS
DE60323133D1 (en) CYCLOHEXYL COMPOUNDS AS CCR5 ANTAGONISTS
RS85404A (en) 4-(n-phenylamino)- quinazolines/quinolines as tyrosine kinase inhibitors
NO20052739L (en) CCR5 antagonists as drugs
NO20085373L (en) P38 inhibitors, their preparation and use
CY1106766T1 (en) PYRIDINE DERIVATIVES AS RAF KINASE INHIBITORS
SE9800836D0 (en) New Compounds
WO2005009367A3 (en) Treatment of diseases with kinase inhibitors
IL179883A0 (en) 4,6-disubstituted pyrimidine derivatives and pharmaceutical compositions containing the same
PT1282418E (en) USE OF PYRAZOLE DERIVATIVES FOR THE TREATMENT OF INFERTILITY